Table 1.
Phenotypes | MSSA, n(%) | MRSA, n(%) | Total, n(%) |
---|---|---|---|
ER-R, CL-S, D+ (iMLSb phenotype) | 7 (9.5) | 19 (48.7) | 26 (23.2) |
ER-R, CL-R (cMLSb phenotype) | 41 (5.61) | 12 (30.7) | 53 (47.3) |
ER-R, CL-S, D− (MS phenotype) | 1 (0.01) | 2 (0.05) | 3 (2.67) |
ER-S, CL-S | 24 (32.8) | 5 (12.8) | 29 (25.8) |
Total, n(%) | 73 (65.5) | 39 (34.5) | 112 |
ER: Erythromycin, CL: Clindamycin, R: Resistant, S: Susceptible.